Panel Discussion: Best Practice for Establishing a HTN Patient Care Medical Based Pathway

Sunday, February 26, 2023

10:15 AM – 10:30 AM ET

Panel Moderator(s)

Judith Veis, MD

Section Director, Nephrology
Medstar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Michael Weber, MD

Professor of Medicine
SUNY Downstate Medical College
Palm Beach Gardens, Florida, United States

Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)
William S. Weintraub, MD

Cardiologist
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Herbert D. Aronow, MD, MPH

Medical Director, Heart & Vascular Service Line
Henry Ford Health
Detroit, Michigan, United States

Disclosure(s): Philips Medical: Consultant (Ongoing); Silk Road Medical: Consultant (Ongoing)
Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

Professor of Medicine
New York University School of Medicine
New York University School of Medicine
New York, New York, United States

Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)
Timir Paul, MD, PhD, FACC, FSCAI

Associate Professor. Program Director, Cardiovascular Disease Fellowship
University of Tennessee at Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

No relationships to disclose
Ileana L. Pina, MD, MPH (she/her/hers)

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC

Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States

No relationships to disclose

Disclosure(s):

Judith Veis, MD: No financial relationships to disclose

Michael Weber, MD: Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

William S. Weintraub, MD: No financial relationships to disclose

Herbert D. Aronow, MD, MPH: Philips Medical: Consultant (Ongoing); Silk Road Medical: Consultant (Ongoing)

Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI: Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)

David E. Kandzari, MD, FACC, FSCAI: Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

Ileana L. Pina, MD, MPH: boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)